Konstantin Linnik moderates MassBio panel “Drug Repurposing and Reformulation: At the Crossroads of IP, Clinical and Business Strategies”Print PDF
Konstantin Linnik, a partner in the Intellectual Property Department and a member of the firm’s Life Sciences practice group, served as a moderator at the Massachusetts Biotechnology Council’s (MassBio) panel “Drug Repurposing and Reformulation: At the Crossroads of IP, Clinical and Business Strategies” on July 18. Konstantin co-chairs MassBio’s Legal & Regulatory committee.
The panel discussed how discovering new uses for existing molecules is now a commonly explored strategy for both clinical development and business growth and explored how repurposing and reformulation can create new markets for successful drugs.
For more information, click here.